Literature DB >> 29259852

Epidemiology, diagnosis, and treatment of Wilson's disease.

Jing Liu1,2, Jing Luan2, Xiaoyan Zhou2, Yazhou Cui2, Jinxiang Han2.   

Abstract

Wilson's disease (WD) is an autosomal recessive disease caused by a mutation of the ATP7B gene, resulting in abnormal copper metabolism. The major clinical features of WD include liver disease, neurological disorders, K-F rings, and osteoporosis. The prevalence of WD in China is higher than that in Western countries. Early diagnosis and lifelong treatment will lead to better outcomes. Drugs such as sodium dimercaptosuccinate (Na-DMPS), Zn, and Gandou Decoction can be used to treat WD. Some studies have shown that the combination of traditional Chinese medicine and Western medicine is the best approach to treating WD. In order to identify better treatments, this article describes the specific clinical symptoms of Wilson's disease, its diagnosis, and treatment options.

Entities:  

Keywords:  D-PCA; Kayser-Fleischer rings; Wilson's disease

Year:  2017        PMID: 29259852      PMCID: PMC5735277          DOI: 10.5582/irdr.2017.01057

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  43 in total

1.  Proceedings: The musculoskeletal features of Wilson's disease: a clinical, radiological, and serological survey.

Authors:  D N Golding; J M Walshe
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

2.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

Review 3.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

4.  Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease.

Authors:  D Hegedus; V Ferencz; P L Lakatos; S Meszaros; P Lakatos; C Horvath; F Szalay
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

5.  Bone status and fractures in 85 adults with Wilson's disease.

Authors:  A-S Quemeneur; J-M Trocello; H-K Ea; A Ostertag; A Leyendecker; J-C Duclos-Vallée; M-C de Vernejoul; F Woimant; F Lioté
Journal:  Osteoporos Int       Date:  2014-07-16       Impact factor: 4.507

6.  Diagnosis and management of Wilson's disease: results of a single center experience.

Authors:  Valentina Medici; Carlo Pietro Trevisan; Renata D'Incà; Michela Barollo; Lucia Zancan; Stefano Fagiuoli; Diego Martines; Paola Irato; Giacomo Carlo Sturniolo
Journal:  J Clin Gastroenterol       Date:  2006 Nov-Dec       Impact factor: 3.062

Review 7.  Current status of human hepatocyte transplantation and its potential for Wilson's disease.

Authors:  Celine Filippi; Anil Dhawan
Journal:  Ann N Y Acad Sci       Date:  2014-03-07       Impact factor: 5.691

8.  Radiologic study of 42 cases of Wilson disease.

Authors:  Y Z Xie; X Z Zhang; X H Xu; Z X Zhang; Y K Feng
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

9.  Hepatolenticular degeneration (Wilson's disease).

Authors:  J M WALSHE
Journal:  Br Med Bull       Date:  1957-05       Impact factor: 4.291

10.  Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations.

Authors:  Xin-Hua Li; Yi Lu; Yun Ling; Qing-Chun Fu; Jie Xu; Guo-Qing Zang; Feng Zhou; Yu De-Min; Yue Han; Dong-Hua Zhang; Qi-Ming Gong; Zhi-Meng Lu; Xiao-Fei Kong; Jian-She Wang; Xin-Xin Zhang
Journal:  BMC Med Genet       Date:  2011-01-11       Impact factor: 2.103

View more
  9 in total

Review 1.  Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD.

Authors:  Sílvia Vilarinho; Veeral Ajmera; Melanie Zheng; Rohit Loomba
Journal:  Hepatology       Date:  2021-10       Impact factor: 17.298

2.  p.P1379S, a benign variant with reduced ATP7B protein level in Wilson Disease.

Authors:  Fan Yi; Sheri A Poskanzer; Candace T Myers; Jenny Thies; Christopher J Collins; Remwilyn Dayuha; Phi Duong; Roderick Houwen; Si Houn Hahn
Journal:  JIMD Rep       Date:  2020-05-19

3.  Hepatic copper accumulation in a young cat with familial variations in the ATP7B gene.

Authors:  Hajime Asada; Mari Kojima; Takuro Nagahara; Yuko Goto-Koshino; James K Chambers; Taisuke Nakagawa; Nozomu Yokoyama; Kazuyuki Uchida; Hajime Tsujimoto; Koichi Ohno
Journal:  J Vet Intern Med       Date:  2018-12-18       Impact factor: 3.333

4.  Wilson's Disease Update: An Indian Perspective.

Authors:  Niraj Kumar; L K Prashant; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2021-10-14       Impact factor: 1.383

5.  Wilson's Disease Update: An Indian Perspective.

Authors:  Kalyan Bhattacharya; Bindu Thankappan
Journal:  Ann Indian Acad Neurol       Date:  2022-02-18       Impact factor: 1.383

6.  Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta-Analysis.

Authors:  Shan Tang; Li Bai; Wei Hou; Zhongjie Hu; Xinyue Chen; Jing Zhao; Chen Liang; Wei Zhang; Zhongping Duan; Sujun Zheng
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

7.  Protective Mechanism of Gandou Decoction in a Copper-Laden Hepatolenticular Degeneration Model: In Vitro Pharmacology and Cell Metabolomics.

Authors:  Fengxia Yin; Mengnan Nian; Na Wang; Hongfei Wu; Huan Wu; Wenchen Zhao; Shijian Cao; Peng Wu; An Zhou
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

8.  High Prevalence of Wilson's Diseases with Low Prevalence of Kayser-Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh.

Authors:  Nuzhat Choudhury; Shamshad B Quraishi; Akm Atiqullah; Md Sakirul Islam Khan; Mamun Al Mahtab; Sheikh Mf Akbar
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jul-Dec

9.  DOTA Glycodendrimers as Cu(II) Complexing Agents and Their Dynamic Interaction Characteristics toward Liposomes.

Authors:  Marianna Carone; Silvia Moreno; Michela Cangiotti; Maria Francesca Ottaviani; Peng Wang; Riccardo Carloni; Dietmar Appelhans
Journal:  Langmuir       Date:  2020-10-20       Impact factor: 3.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.